Navigation Links
India Pharmaceutical Sector Reviewed by Kelly Scientific Publications in In-demand Report Now Available at MarketPublishers.com
Date:7/31/2013

London, UK (PRWEB) July 31, 2013

India’s pharmaceutical market has experienced unprecedented growth recently to currently stand at USD 11 billion in value. The robust growth of the sector is spurred to a large extent by rising domestic consumption levels in tandem with the increasing demand from export markets. The national pharmaceutical industry has also seen a considerable breakthrough in the infrastructure development, science and technology base, as well as the introduction of new products into the market.

Pharmaceutical sales in India are anticipated to go beyond USD 73.9 billion by end-2020. Over the next decade, the country is likely to turn into a significant player in the worldwide pharmaceutical arena and become a major hub for all pharmaceutical research and manufacturing needs.

In-demand research study “Pharmaceutical Market: India, A Competitive Industry Analysis” worked out by Kelly Scientific Publications has been recently published by Market Publishers Ltd.

Report Details:

Title: Pharmaceutical Market: India, A Competitive Industry Analysis
Published: May, 2013
Pages:    161
Price:    US$ 2,600.00
http://marketpublishers.com/report/life_sciences/pharmaceuticals/pharmaceutical-market-india-a-competitive-industry-analysis.html    

The report provides a comprehensive analysis of the Indian pharmaceutical market. It contains critical information on the market size and segmentation; presents insightful market assessment by segment, therapeutic area, disease category and company; includes a SWOT analysis. The research study characterizes the regulative framework and business environment in the country; unveils qualitative and quantitative data on the market performance; identifies major factors driving the market and outlines key industry opportunities and challenges. The report delves into the competitive landscape, profiles the leading market participants and gives details on their operations, products, financials and business strategy. Moreover, the report discusses future prospects of the Indian pharma industry.

Report Scope:

  •     Epidemiology and disease overview.
  •     Twelfth five year plan – a boost for scientific research and development.
  •     Description of the economic and business environment.
  •     In-depth analysis of the Indian pharmaceutical market.
  •     Critical data on the market performance.
  •     Indian pharmaceutical company profiles and financial data.
  •     Clear picture of the competitive scenario.
  •     SWOT analysis.
  •     Comprehensive market assessment by disease category, therapeutic area, segment and company.
  •     Industry future outlook through 2017.

More research studies by the publisher can be found at Kelly Scientific Publications page.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10983654.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Nanounity Announces New Characterization Tools for the 2013 Microscopy & Microanalysis Annual Meeting in Indianapolis, August 4-8
2. Navigating the Dynamic Indian Clinical Trial Landscape, New Webinar Hosted by Xtalks
3. StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500
4. Nutra Pharma Patent and Trademarks Published in India
5. Indigo Biosystems Among “Best Places to Work” in Indiana
6. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
7. Indiana’s Life Sciences Industry Economic Impact Tops $50 billion
8. Atharva Lifesciences Consulting Releases the Biggest Ever Compilation of Science Funding Sources for India
9. Webinar to Discuss Biosimilar Regulatory Guidelines in India and Emerging Markets
10. SAHYOG: Future of Bio-based Economy in India and European Union
11. Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018: China Market Research Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... 2016 , ... Clinovo , the cloud-based eClinical software ... Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner Program ... San Mateo, California on February 10th and 11th. Watch 2-min video . ...
(Date:2/9/2016)...  DNAtrix, a clinical stage, biotechnology company ... its lead product, DNX-2401, has been designated ... medicinal product for the treatment of glioma. ... approximately 25,000 people a year in the ... --> http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
(Date:2/9/2016)... LONDON , Feb. 9, 2016 /PRNewswire/ ... (PTP1B) Inhibitors-Pipeline Insights, 2016", report provides in ... their development activities around the Protein-Tyrosine Phosphatase ... the product profiles in various stages of ... Phase II, Phase III and Preregistration. Report ...
(Date:2/8/2016)... N.C. , Feb. 8, 2016 Novan, Inc. today ... Chairman of the Board of Directors of Novan. In addition, ... North Carolina . --> ... Company also announced that it received a total of $32.8 million ... 2015 from its private investor network originating throughout the Research Triangle ...
Breaking Biology Technology:
(Date:2/3/2016)... 3, 2016 ... the "Emotion Detection and Recognition Market ... Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020" ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
Breaking Biology News(10 mins):